Wondering if Recursion Pharmaceuticals at around US$4.67 a share is priced for its potential or still misunderstood by the ...

New research shows AI can analyze language with skills rivaling human experts. Credits: Jernej Furman from Slovenia, CC BY 2.0, via Wikimedia Commons Artificial intelligence (AI) systems are showing ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but ...

A syntax checker was designed based on the syntax of ALGOL as described in the ALGOL 60 Report [Communications of the ACM, May 1960]. Since the definition of the elements of the language is recursive ...

The use of the Kleene regular expression notation for describing algebraic language syntax, in particular of ALGOL, is described in this paper. A FORTRAN II computer program for carrying out the ...